Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at the beginning at Jun. 30, 2022 $ 2,882 $ 0 $ 152,454 $ (148,327) $ (1,245)
Balance at the beginning (In shares) at Jun. 30, 2022   480,688      
Issuance of common stock, pre-funded warrants, and common Warrants sold for cash, net of offering costs 16,015 $ 0 16,015    
Issuance of common stock, pre-funded warrants, and common Warrants sold for cash, net of offering costs, Shares   1,037,520      
Share-based compensation 302   302    
Foreign currency translation gain 507       507
Net loss (5,093)     (5,093)  
Balance at end at Sep. 30, 2022 14,613 $ 0 168,771 (153,420) (738)
Balance at end (In shares) at Sep. 30, 2022   1,518,208      
Balance at the beginning at Jun. 30, 2023 202 $ 0 168,921 (167,889) (830)
Balance at the beginning (In shares) at Jun. 30, 2023   1,671,485      
Issuance of common stock, pre-funded warrants, and common Warrants sold for cash, net of offering costs 27,919 $ 0 27,919 0 0
Issuance of common stock, pre-funded warrants, and common Warrants sold for cash, net of offering costs, Shares   875,949      
Share-based compensation 91   91    
Foreign currency translation gain 50       50
Net loss (5,954)     (5,954)  
Balance at end at Sep. 30, 2023 $ 22,308 $ 0 $ 196,931 $ (173,843) $ (780)
Balance at end (In shares) at Sep. 30, 2023   2,547,434